Skip to main content
GRCE logo

GRCE · Grace Therapeutics, Inc.

Track GRCE — free
$2.08 -0.02 (-0.95%)
Market Cap
$44.18M
Shares
21.04M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1444192 CUSIP 00439U104 13F (30d) 27 filings 27 filers Visit website Investor relations